webinar register page

Management of Primary and Secondary Immunodeficiency with Subcutaneous Immunoglobulin & Real-world Experience
Join Dr. Paul Keith (McMaster University) for a 45-minute webinar that will discuss the warning signs of immunodeficiency, treatment options, and the use of subcutaneous immunoglobulin in the treatment of immunodeficiency.

In addition, Dr. Keith will review the interim results of the Real-World Canadian CUVITRU Noninterventional Study in Subjects Transitioning to Subcutaneous Immunoglobulin (CANCUN) – a study aimed at understanding the patient experience of transitioning to CUVITRU.

May 14, 2021 12:30 PM in Eastern Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Paul Keith
Dr. Keith is an Associate Professor of Medicine, in the Division of Allergy and Clinical Immunology at McMaster University in Hamilton. He is extensively involved in medical education in both academic and community settings, and has an active hospital based clinical practice in adult and pediatric allergy and clinical immunology at the McMaster Site of the Hamilton Health Sciences Corporation and at the Firestone Institute of Respiratory Health at St Joseph's Healthcare in Hamilton, Ontario Research interest and activities are focused on rhinitis, asthma, allergen immunotherapy, nasal polyposis, chronic urticaria, anaphylaxis and hereditary angioedema. He is the past President of the Canadian Society of Allergy and Clinical Immunology. Educational activities include participation in the continuing education for physicians, allied health professionals and the community, as well as involvement in the development of practice guidelines in rhinitis, anaphylaxis and hereditary angioedema.